Jiangsu Yahong Meditech Co., Ltd. Class ASSE: 688176

"JIANGSU YAHONG MEDITECH CO., LTD."Announcement on Voluntary Disclosure of Completion of First Subject Enrollment in the Phase I Clinical Trial of APL-2501

Sep 23, 2026 · Issued by Jiangsu Yahong Meditech Co., Ltd. Class A via Shanghai Stock Exchange

Filed with SSE · Sep 23, 2026

Announcement on Voluntary Disclosure of Completion of First Subject Enrollment in the Phase I Clinical Trial of APL-2501

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Company analysis

Earlier from Jiangsu Yahong Meditech Co., Ltd. Class A

"JIANGSU YAHONG MEDITECH CO., LTD."Announcement on Change of Core Technical PersonnelSep 19
"JIANGSU YAHONG MEDITECH CO., LTD."Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug IndustrySep 9
"JIANGSU YAHONG MEDITECH CO., LTD."Special Report on the Deposit and Actual Use of Raised Funds for the First Half of 2026Aug 29
"Jiangsu Asieris Pharmaceuticals Co., Ltd."Announcement on Voluntary Disclosure of APLD-2304 Obtaining EU CE CertificationAug 28

All Jiangsu Yahong Meditech Co., Ltd. Class A news releases